These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1542433)

  • 1. Chronic treatment with ascorbic acid inhibits the morphine withdrawal response in guinea-pigs.
    Johnston PA; Chahl LA
    Neurosci Lett; 1992 Jan; 135(1):23-7. PubMed ID: 1542433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement by haloperidol of the locomotor response induced by naloxone in morphine-treated guinea pigs.
    Chahl LA; Kavanagh CA; Corlis A
    Neurosci Lett; 1989 Jan; 96(2):213-7. PubMed ID: 2927723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capsaicin pretreatment does not inhibit the opioid withdrawal response in guinea-pigs.
    Chahl LA
    Eur J Pharmacol; 1988 Dec; 158(1-2):91-8. PubMed ID: 3220120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kappa-opioid receptor agonist U50,488H induces acute physical dependence in guinea-pigs.
    Brent PJ; Chahl LA; Cantarell PA; Kavanagh C
    Eur J Pharmacol; 1993 Sep; 241(2-3):149-56. PubMed ID: 7902288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tachykinin antagonists inhibit the morphine withdrawal response in guinea-pigs.
    Johnston PA; Chahl LA
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Mar; 343(3):283-8. PubMed ID: 1714041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of the opiate withdrawal response by antipsychotic drugs in guinea-pigs is not mediated by sigma binding sites.
    Brent PJ; Chahl LA
    Eur Neuropsychopharmacol; 1993 Mar; 3(1):23-32. PubMed ID: 8097127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the nonpeptide NK-1 receptor antagonist CP-96,345 on the morphine withdrawal response of guinea-pigs.
    Chahl LA; Johnston PA
    Regul Pept; 1993 Jul; 46(1-2):373-5. PubMed ID: 7692540
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of pertussis toxin on behavioural responses of guinea-pigs to centrally administered substance P, quinpirole, carbachol, U-50,488H, morphine and morphine withdrawal.
    Bot G; Chahl LA
    Eur J Pharmacol; 1993 Jan; 231(1):53-60. PubMed ID: 7680319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma catecholamine concentrations during morphine withdrawal in conscious guinea-pigs.
    Brent PJ; Johnston PA; Chahl LA
    Clin Exp Pharmacol Physiol; 1987 Aug; 14(8):623-31. PubMed ID: 3440321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in sensitivity to apomorphine during morphine dependence and withdrawal in rats.
    Cox B; Ary M; Lomax P
    J Pharmacol Exp Ther; 1976 Mar; 196(3):637-41. PubMed ID: 944260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of morphine withdrawal to naloxone by interferon.
    Dafny N; Zielinksi M; Reyes-Vazquez C
    Neuropeptides; 1983 Oct; 3(6):453-63. PubMed ID: 6420721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sinomenine on morphine dependence in isolated guinea pig ileum.
    Wang CY; Mo ZX; Tu HH
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Apr; 23(4):329-31. PubMed ID: 12697465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locomotor activity and contracture of isolated ileum precipitated by naloxone following treatment of guinea-pigs with a single dose of morphine.
    Chahl LA; Thornton CA
    J Pharm Pharmacol; 1987 Jan; 39(1):52-4. PubMed ID: 2434641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between the in vivo and an in vitro expression of opiate withdrawal precipitated by naloxone: their antagonism by l-(-)-delta9-tetrahydrocannabinol.
    Frederickson RC; Hewes CR; Aiken JW
    J Pharmacol Exp Ther; 1976 Nov; 199(2):375-84. PubMed ID: 988178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RP 67580, a selective antagonist of neurokinin-1 receptors, modifies some of the naloxone-precipitated morphine withdrawal signs in rats.
    Maldonado R; Girdlestone D; Roques BP
    Neurosci Lett; 1993 Jun; 156(1-2):135-40. PubMed ID: 7692360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the NO/NMDA pathways in the development of morphine withdrawal induced by naloxone in vitro.
    Gabra BH; Afify EA; Daabees TT; Abou Zeit-Har MS
    Pharmacol Res; 2005 Apr; 51(4):319-27. PubMed ID: 15683745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential involvement of tyrosine phosphatase and calpain-related pathways in opioid withdrawal syndrome in mice.
    Rehni AK; Singh N
    Behav Pharmacol; 2012 Jun; 23(3):302-9. PubMed ID: 22495184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK; Bhateja P; Singh TG; Singh N
    Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitization to morphine withdrawal in guinea-pigs.
    Mizutani A; Arvidsson J; Chahl LA
    Eur J Pharmacol; 2005 Feb; 509(2-3):135-43. PubMed ID: 15733548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of orally active enkephalinase inhibitors on morphine withdrawal syndrome.
    Dzoljic MR; Bokszanska A; Korenhof AM; Kaplan CD; Dzoljic M; Rupreht J; Zijlstra FJ; Brinkman EC; Cappendijk SL
    Neuroreport; 1992 Jul; 3(7):637-40. PubMed ID: 1421123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.